Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Change in Cash (2016 - 2025)

Jaguar Health (JAGX) has disclosed Change in Cash for 11 consecutive years, with $1.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Cash rose 147.48% to $1.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$9.7 million, a 197.0% decrease, with the full-year FY2024 number at $1.5 million, up 53.3% from a year prior.
  • Change in Cash was $1.3 million for Q3 2025 at Jaguar Health, up from -$3.5 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $24.2 million in Q1 2021 to a low of -$19.5 million in Q3 2021.
  • A 5-year average of -$240157.9 and a median of -$338000.0 in 2021 define the central range for Change in Cash.
  • Peak YoY movement for Change in Cash: plummeted 2397.63% in 2022, then surged 2097.04% in 2023.
  • Jaguar Health's Change in Cash stood at $4.7 million in 2021, then tumbled by 208.9% to -$5.1 million in 2022, then soared by 163.69% to $3.2 million in 2023, then crashed by 262.41% to -$5.3 million in 2024, then skyrocketed by 125.06% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Change in Cash are $1.3 million (Q3 2025), -$3.5 million (Q2 2025), and -$2.3 million (Q1 2025).